These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lipid disorders in type 1 and type 2 diabetes. Goldberg RB; Capuzzi D Clin Lab Med; 2001 Mar; 21(1):147-72, vii. PubMed ID: 11321932 [TBL] [Abstract][Full Text] [Related]
25. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173 [No Abstract] [Full Text] [Related]
26. [Coronary risk assessment in subjects with type 2 diabetes mellitus. General population-based scores or specific scores?]. Hernáez R; Choque L; Giménez M; Costa A; Márquez JI; Conget I Rev Esp Cardiol; 2004 Jun; 57(6):577-80. PubMed ID: 15225505 [TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus: biological determinants of atherosclerosis and restenosis. Marso SP; Mak KH; Topol EJ Semin Interv Cardiol; 1999 Sep; 4(3):129-43. PubMed ID: 10545619 [TBL] [Abstract][Full Text] [Related]
29. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview. Janka HU; Standl E Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556 [No Abstract] [Full Text] [Related]
31. The evidence for lipid lowering: type 2 diabetes and coronary heart disease risk. Townsend D; Davis R Prof Nurse; 2004 Jun; 19(10):38-40. PubMed ID: 15233071 [TBL] [Abstract][Full Text] [Related]
32. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review. Paulo S; Fernandes S; Vizinho R; Carneiro AV Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698 [TBL] [Abstract][Full Text] [Related]
33. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Tenenbaum A; Motro M; Fisman EZ; Adler Y; Shemesh J; Tanne D; Leor J; Boyko V; Schwammenthal E; Behar S Eur Heart J; 2005 Oct; 26(19):2032-8. PubMed ID: 15872029 [TBL] [Abstract][Full Text] [Related]
34. Advances in the understanding of diabetic vascular disease. Fujii S J Cardiovasc Risk; 1997 Apr; 4(2):67-9. PubMed ID: 9304486 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk and prevention in diabetes mellitus. Roberts AW Clin Med (Lond); 2010 Oct; 10(5):495-9. PubMed ID: 21117387 [No Abstract] [Full Text] [Related]
37. Lipid lowering drugs in diabetes: absolute risk reduction is what counts. Lewis LS BMJ; 2006 May; 332(7552):1272. PubMed ID: 16735344 [No Abstract] [Full Text] [Related]
38. Hyperglycaemia and coronary heart disease: the meta picture. Mazzone T Lancet; 2009 May; 373(9677):1737-8. PubMed ID: 19465212 [No Abstract] [Full Text] [Related]